Table 4 Proportion of patients receiving each treatment class within each regimen
Treatment | Any regimen | 1st regimen | 2nd regimen | 3rd regimen | 4th regimen |
|---|---|---|---|---|---|
Pharmacotherapies | |||||
SSRI | 61.9% | 49.6% | 43.9% | 38.9% | 36.5% |
Other antidepressants | 51.3% | 37.8% | 34.3% | 34.9% | 36.7% |
Anxiolytic | 50.8% | 36.1% | 31.5% | 33.9% | 35.0% |
Anticonvulsant | 43.6% | 29.3% | 33.4% | 36.7% | 39.6% |
SNRI | 26.9% | 18.8% | 20.0% | 21.1% | 22.9% |
Atypical antipsychotic | 20.1% | 13.8% | 4.7% | 3.2% | 2.8% |
Hypnotics and Sedatives | 19.1% | 9.6% | 11.0% | 12.6% | 14.7% |
Psychostimulant | 9.3% | 4.6% | 6.9% | 8.5% | 9.8% |
Tricyclic | 7.1% | 3.6% | 4.2% | 4.9% | 6.0% |
Lithium | 2.6% | 1.3% | 1.6% | 2.0% | 2.4% |
MAOI | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% |
Procedures | |||||
Electroconvulsive therapy | 1.4% | 1.0% | 0.5% | 0.5% | 0.5% |
Transcranial magnetic stimulation | 0.4% | 0.1% | 0.1% | 0.2% | 0.3% |